首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
admin
2014-09-17
33
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ve balked at divulging tests when the results are not what they’d hoped to see. The furor has centered around the use of anti- depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Internet. But that seems unlikely to satisfy some members of Congress, who are expected to ! ntroduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hash’ t been approved for that use.
Antidepressant drugs "have some serious side effects ... that seem to be much more common than people realize.., much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the
past decade. In 1995, less than half of people getting mental health treatment —40 percent- got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’ s sup- posed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money.
Who is willingly to introduce the registry of drug trials?
选项
A、The pharmaceutical industry.
B、US Food and Drug Administration.
C、The Congress.
D、The drug companies.
答案
C
解析
下面哪一方是愿意引进药品临床试验结果登记这一方法的?由原文第二段可知,pharmaceutical industry和US Food and Drug Administration都是迫于压力的,更不用说此方法会对其产生不利的药品公司了。
转载请注明原文地址:https://kaotiyun.com/show/aTdO777K
0
专业英语八级
相关试题推荐
DuringtheBritishCivilWar,thesupportersofthekingwerecalled______
AGatedCommunityfarOrganDonorsAmericansloveasquaredeal.Theideaofthesomethingforsomething,liesattheheart
EconomicDeathSpiralJustrecentlythetrusteesofSocialSecurityandMedicareissuedtheirannualreportsontheprograms
GorkyParkisfamousformanythings,notmanyofthemgood.ForMuscovites,theircity’sbiggestgreenspaceusedtobeknowna
Properarrangementofclassroomspaceisimportanttoencouraginginteraction.Today’scorporationshirehumanengineeringspec
Properarrangementofclassroomspaceisimportanttoencouraginginteraction.Today’scorporationshirehumanengineeringspec
Properarrangementofclassroomspaceisimportanttoencouraginginteraction.Today’scorporationshirehumanengineeringspec
InChina,someofthemuseumschargeforadmission,withthefeebeingusedtocoverthecostsofoperation,maintenance,acquis
Asaromanticpoet,WilliamWordsworthadvocatedthefollowingEXCEPT
Literatureisameansbywhichweknowourselves.Byitwemeet【M1】______futureselves,andrecognizepastselves;aga
随机试题
男,62岁,反复心绞痛1年,3小时前突发心前区痛,向左肩臂放射,伴大汗,含硝酸甘油无效。血压100/60mmHg,心率92次/分,心律齐,心尖部Ⅱ级收缩期杂音。双肺检查未见异常。全科医生接诊后初步诊断印象是
下列等式中正确的是( )。
没定泥水平衡式盾构泥水压控制值时,预备压通常取()kN/m2。
下列不属于风险调整后收益指标的是()。
从事会计职称考前培训的D公司,采取在一些三线城市率先投入大量资本建立大型面授培训机构的战略。由于三线城市的市场空间狭小,不能支撑两个竞争者同时盈利,D公司的竞争者只好放弃竞争。D公司的竞争优势来源于()。
为什么说在教育过程中对学生严格要求与尊重信任是辩证的统一?
Google服务列表中域名为scholar.google.cn是主要进行()的搜索。
根据以下情境材料.回答问题。2019年清明前夕,甲市公安局情报中心根据《甲市2018年清明节期间陵园警情分析报告》,对2019年清明节期间全市陵园(宝福山、灵鼎山、龙归园,分别对应管辖派出所为南山派出所、永丰派出所、团合派出所)社会治安状况进行预测,
分析程序语言提供的传值调用机制是将(14)。
C语言程序的模块化通过以下哪个选项来实现
最新回复
(
0
)